Institutes

Harvard’s Wyss Institute and Brigham and Women’s Hospital launch Diagnostic Accelerator

Retrieved on: 
Friday, July 9, 2021
Harvard Medical School, Harvard University, Wyss Institute for Biologically Inspired Engineering, Wyss Institute, Brigham and Women's Faulkner Hospital, Brigham and Women's Hospital, Wyss, Brigham, Organizations, Hospitals, Institutes

Boston, July 09, 2021 (GLOBE NEWSWIRE) -- (Boston) Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Bostons Brigham and Women Hospital (Brigham) announce their newly founded Diagnostic Accelerator (BrighamWyss DxA).

Key Points: 
  • Boston, July 09, 2021 (GLOBE NEWSWIRE) -- (Boston) Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Bostons Brigham and Women Hospital (Brigham) announce their newly founded Diagnostic Accelerator (BrighamWyss DxA).
  • In 2019, the Institute focused its 10thInternational Wyss Institute Symposium on diagnostic challenges and new technological approaches to address them.
  • In the Wyss Diagnostic Grand Rounds series of events held continually at the Wyss Institute, individual Brigham clinicians have been presenting unmet clinical needs in their fields to Wyss researchers and engineers, which has resulted in multiple collaborations.
  • Brigham Health, a global leader in creating a healthier world, consists of Brigham and Women's Hospital, Brigham and Womens Faulkner Hospital, the Brigham and Womens Physicians Organization and many related facilities and programs.

Battelle, The Ohio State University and Northwestern University Collaborate to Tackle COVID-19 Infodemic in Real Time

Retrieved on: 
Wednesday, May 26, 2021
Security, Science, Other Science, Technology, Software, Battelle Memorial Institute, University District, Columbus, Ohio, John Glenn College of Public Affairs, Intelligence Advanced Research Projects Activity, Battelle, Organizations, Public policy, Institutes

A new collaborative effort between Battelle, the Ohio State University, and Northwestern University, sponsored by a $1 million grant from the Intelligence Advanced Research Projects Activity (IARPA), aims to address this problem by assessing the risk of COVID-19 misinformation in near real time.

Key Points: 
  • A new collaborative effort between Battelle, the Ohio State University, and Northwestern University, sponsored by a $1 million grant from the Intelligence Advanced Research Projects Activity (IARPA), aims to address this problem by assessing the risk of COVID-19 misinformation in near real time.
  • This is a critical step in prioritizing mitigation efforts and can facilitate a more targeted approach to combating the infodemic.
  • Ohio State Battelle Center for Science, Engineering, and Public Policy is part of the John Glenn College of Public Affairs.
  • Through research and professional development programming, Ohio State Battelle Center aims to tackle challenges that require multiple disciplines while preparing students to be innovative in the public interest.

Harvard University licenses its nasal swab collection technology, developed at the Wyss Institute and Harvard Medical School, to Mass. startup Rhinostics

Retrieved on: 
Tuesday, May 4, 2021
Wyss Institute, Biological specimens, Sampling, Swab, Wyss, Organizations, Articles, Institutes

b'BOSTON, May 4, 2021 /PRNewswire/ --The Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard Medical School (HMS) and the Massachusetts-based startup Rhinostics announced today that the University\'s sample collection swab and high-throughput automation technologies have been licensed to Rhinostics.

Key Points: 
  • b'BOSTON, May 4, 2021 /PRNewswire/ --The Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard Medical School (HMS) and the Massachusetts-based startup Rhinostics announced today that the University\'s sample collection swab and high-throughput automation technologies have been licensed to Rhinostics.
  • "We were trying to circumvent supply and performance limitations of swabs when I heard about the Wyss Institute\'s swab technology at a MASS CPR online event.
  • Novak had independently thought about possibilities to solve the problem of automatically removing the swab from the sample collection device.
  • The RHINOstic product is registered as Class I exempt medical device with the FDA and is available for purchase.

Instem Acquires Market Leader d-wise to Further Accelerate Life Science Development

Retrieved on: 
Monday, March 22, 2021
Research, Technology, Clinical trials, Software, Biotechnology, General Health, Pharmaceutical, Health, Data management, Science, Institute for Stem Cell Science and Regenerative Medicine, Stem cell research, Institutes

More than a growth-based acquisition, this can truly help transform the industry landscape, states Phil Reason, CEO at Instem.

Key Points: 
  • More than a growth-based acquisition, this can truly help transform the industry landscape, states Phil Reason, CEO at Instem.
  • By providing solutions across a wide area of the life science R&D continuum, Im certain that as part of Instem we will accelerate clinical development timelines and have an even broader impact on human health and wellbeing.
  • A global provider of leading software solutions and scientific insight services, Instem is helping clients bring their life enhancing products to market faster.
  • Across the entire drug development value chain, every day Instem solutions are meeting the rapidly expanding needs of life science organizations for data-driven decision making, leading to safer, more effective products.

Leaps.org & Aspen Institute Feature “COVID Vaccines & the Return to Life,” March 11 Webinar with Major Health & Science Experts

Retrieved on: 
Thursday, March 11, 2021
Health, Infectious diseases, Other Health, Research, Science, Pharmaceutical, Biotechnology, Florida Atlantic University, La Jolla, San Diego, Scripps Research, Yale School of Medicine, Institutes

Onyema Ogbuagu, MBBCh , Associate Professor at Yale School of Medicine and Yale Medicine infectious disease specialist treating COVID-19 patients and leading Yales COVID-19 vaccine trials.

Key Points: 
  • Onyema Ogbuagu, MBBCh , Associate Professor at Yale School of Medicine and Yale Medicine infectious disease specialist treating COVID-19 patients and leading Yales COVID-19 vaccine trials.
  • , cardiologist, scientist, professor of molecular medicine, and the director and founder of Scripps Research Translational Institute.
  • With generous support from the Gordon and Betty Moore Foundation and the Howard Hughes Medical Institute.
  • Leaps.org publishes award-winning journalism, popularizes scientific progress on social media, and hosts forums about innovation, ethics, and the future of humanity.

Dr. Wayne A. I. Frederick Elected to Battelle Board of Directors

Retrieved on: 
Monday, February 22, 2021
Health, Training, Continuing, Philanthropy, Defense, Other Science, University, Research, Other Defense, Contracts, Education, General Health, Foundation, Science, Battelle, Acumen, Organizations, Science and technology, Institutes

Battelle announced today that Dr. Wayne A. I. Frederick, current president of Howard University and the Charles R. Drew Professor of Surgery, has been elected to the Battelle Board of Directors.

Key Points: 
  • Battelle announced today that Dr. Wayne A. I. Frederick, current president of Howard University and the Charles R. Drew Professor of Surgery, has been elected to the Battelle Board of Directors.
  • Waynes combination of medical expertise and business acumen will bring a unique and valuable perspective to Battelles board and help to advance Battelles mission, said Board Chairman John Welch.
  • Im honored and excited to join the Battelle board, said Frederick.
  • Battelle is a unique organization bringing innovative technologies and solutions to rapidly changing markets including healthcare, environmental and national security.

SwRI Announces Record 2020 Consolidated Revenues of Nearly $696 Million

Retrieved on: 
Wednesday, February 17, 2021
Science, Other Science, Research, Other Technology, Technology, Southwest Research Institute, Institutes, WRI, Organizations

Southwest Research Institute announced consolidated revenues of nearly $696 million in fiscal year 2020, up more than 3% from 2019 and the highest ever recorded by the Institute.

Key Points: 
  • Southwest Research Institute announced consolidated revenues of nearly $696 million in fiscal year 2020, up more than 3% from 2019 and the highest ever recorded by the Institute.
  • Internal research and development spending increased 24%, topping $10 million for the first time.
  • The Institutes Advisory Trustees, Board of Directors and special guests met virtually for the 73rd Annual Meeting, highlighted by presentations about several innovative research and development programs underway at SwRI in 2020.
  • Wayne S. Alexander, retired president of SBC Southwestern Bell, was reelected chair of the board, his third time serving in that capacity.

Government of Canada continues to invest in research to inform protection measures for vulnerable whale populations

Retrieved on: 
Tuesday, February 16, 2021
Marine mammal, Woods Hole Oceanographic Institution, Massachusetts, Institutes, States of the United States

As a Government we are committed to protecting them with methods that are sustainable and grounded in the best-available research and technology.

Key Points: 
  • As a Government we are committed to protecting them with methods that are sustainable and grounded in the best-available research and technology.
  • Today, the Minister of Fisheries, Oceans and the Canadian Coast Guard, the Honourable Bernadette Jordan, announced $806,759 in funding for marine mammal research.
  • Through this Initiative, the Woods Hole Oceanographic Institution received $325,508 over two years to test a ship-based infrared camera whale detection system capable of detecting whale blows in near real-time.
  • "CHORUS Research Institute is very grateful to Fisheries and Oceans Canada for its financial support for this project.

How Unmanned Underwater Vehicles Could Become Easier to Detect - new research from Draper, MIT

Retrieved on: 
Monday, January 25, 2021
Unmanned underwater vehicle, Woods Hole Oceanographic Institution, WHOI, Robot, Uncrewed vehicle, Massachusetts, Institutes, States of the United States

Researchers at Draper, Massachusetts Institute of Technology (MIT) and Woods Hole Oceanographic Institute (WHOI) have developed an acoustic remote sensing method for high-precision propeller rotation and speed estimation of unmanned underwater vehicles.

Key Points: 
  • Researchers at Draper, Massachusetts Institute of Technology (MIT) and Woods Hole Oceanographic Institute (WHOI) have developed an acoustic remote sensing method for high-precision propeller rotation and speed estimation of unmanned underwater vehicles.
  • The new method is detailed in a study published in the Journal of the Acoustical Society of America.
  • UUVs are marine platforms that are untethered and autonomous and often used for a variety of applications, including national security and ocean exploration .
  • The robots selected for this study belong to the smallest class of vehicles called micro-UUVs, which have a diameter of six or fewer inches.

Impact NRS LLC Creates Plantae Biosciences LTD to Develop and Commercialize Highly Impactful Multidisciplinary Discoveries in Plant Sciences in collaboration with Yeda, the commercial arm of the Weizmann Institute of Science

Retrieved on: 
Tuesday, January 5, 2021
Yeda, Weizmann Institute of Science, Weizmann, Institutes

In the sub-ranking for Life and Earth Sciences, the Weizmann Institute of Science was ranked fourth in the world.

Key Points: 
  • In the sub-ranking for Life and Earth Sciences, the Weizmann Institute of Science was ranked fourth in the world.
  • Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science.
  • Through its operating subsidiaries, Impact NRS is at the forefront of life and earth sciences, including in oncology diagnostics, data science, gene-editing, microbiome and agri-tech.
  • Impact NRS LLC is headquartered in New York, with innovation labs and offices in Rensselaer and Israel.